PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
12-Sep-2024 Epitopea Awarded Grant from Innovate UK’s Cancer Therapeutics Programme Epitopea
12-Sep-2024 KADANS SCIENCE PARTNER WELCOMES NEW TENANT MYRICX BIO TO LONDON INNOVATION CENTRE AT CANARY WHARF Kadans Science Partner
12-Sep-2024 Arctoris acquires Eli Lilly ‘Life Science Studio’ laboratory Arctoris
12-Sep-2024 Vapourtec invests in future with Bristol CDT partnership Vapourtec
12-Sep-2024 QL Biopharm Presented Results from Phase 1c Clinical Study on its Novel Once-Monthly GLP-1RA ZT002 at EASD 2024 Beijing QL Biopharmaceutical Co., Ltd
12-Sep-2024 Birmingham Health Partners Centre for Regulatory Science and Innovation director appointed University of Birmingham
11-Sep-2024 Envision Pharma Group launches EnvisionOne Insights: A unified data and analytics solution for medical affairs Envision Pharma Group
06-Sep-2024 Xinnate presents TCP-25 data at international dermatology congress Xinnate AB
06-Sep-2024 PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies PureTech Health plc
06-Sep-2024 Asgard Therapeutics’ study published in Science showing proof-of-concept and strong anti-tumor responses via in vivo cell reprogramming with lead program AT-108 Asgard Therapeutics
06-Sep-2024 Realheart to Present Positive Results From Two Preclinical Studies Evaluating Treatment Safety of Its Total Artificial Heart at ISMCS 2024 Scandinavian Real Heart AB
06-Sep-2024 In a fixed dose study, once weekly insulin efsitora alfa leads to HbA1C reduction similar to daily insulin Eli Lilly and Company
06-Sep-2024 Crick Skylab opens as MSD commence new research programmes The Francis Crick Institute
06-Sep-2024 EDX MEDICAL APPOINTS CHIEF COMMERCIAL OFFICER EDX Medical Group plc
06-Sep-2024 ENA Respiratory Announces Extension of U.S. Department of Defense Funding for Novel Prophylactic Antiviral ENA Respiratory
06-Sep-2024 Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule Laverock Therapeutics
06-Sep-2024 European Commission Grants Orphan Drug Designation for Vivet Therapeutics Gene Therapy Product for the Treatment of Cerebrotendinous Xanthomatosis (CTX) Vivet Therapeutics
06-Sep-2024 MHRA licenses first in new class of treatment for patients with endometriosis symptoms in the UK Gedeon Richter UK Ltd
06-Sep-2024 Industry calls on government to boost investment in commercial clinical trial capacity to drive £3 billion extra economic growth, 26,000 new jobs ABPI
04-Sep-2024 Innovation Passport Award CRISM Therapeutics Corporation